Daniel Sumarriva: Discussing personalized treatments and digital oncology at ESMO24

Daniel Sumarriva, Senior Director of Molecular Science Liaisons at Caris Life Sciences, shared a post by Heber Reyes, Medical Scientific Liaison at Astellas Pharma, on LinkedIn, adding:

”A pleasure to connect with my Mexican colleague Heber Reyes during ESMO24. So true, we were just discussing this earlier today.. personalized treatments, AI, and digital oncology, the future is already here!”

Quoting Heber Reyes’s post:

”This is our future – oncology will be AI-driven, globally-focused, from policy making, patient advocacy and LMIC educational endeavors ESMO24 (presented by Andres Cervantes) so proud to be a member.”

Source: Daniel Sumarriva/LinkedIn and Heber Reyes/LinkedIn